Chen HH - Search Results

1

A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas.

Lin MH, Chen JS, Chen HH, Su WC. Lin MH, et al. Among authors: chen hh, chen js. Chemotherapy. 2003 Jun;49(3):154-8. doi: 10.1159/000070622. Chemotherapy. 2003. PMID: 12815209 Clinical Trial.

2

p53 and c-erbB-2 but not bcl-2 are predictive of metastasis-free survival in breast cancer patients receiving post-mastectomy adjuvant radiotherapy in Taiwan.

Chen HH, Su WC, Guo HR, Chang TW, Lee WY. Chen HH, et al. Jpn J Clin Oncol. 2002 Sep;32(9):332-9. doi: 10.1093/jjco/hyf076. Jpn J Clin Oncol. 2002. PMID: 12417598

3

Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study.

Su WC, Lai WW, Chen HH, Hsiue TR, Chen CW, Huang WT, Chen TY, Tsao CJ, Wang NS. Su WC, et al. Among authors: chen hh, chen cw, chen ty. Oncology. 2003;64(1):18-24. doi: 10.1159/000066516. Oncology. 2003. PMID: 12457027 Clinical Trial.

4

Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.

Hung TL, Chen FF, Liu JM, Lai WW, Hsiao AL, Huang WT, Chen HH, Su WC. Hung TL, et al. Among authors: chen ff, chen hh. Clin Cancer Res. 2003 Jul;9(7):2605-12. Clin Cancer Res. 2003. PMID: 12855637

5

High-dose chemotherapy and hematopoietic stem cell transplantation for patients with nasopharyngeal cancer: a feasibility study.

Chen TY, Chen HH, Su WC, Tsao CJ. Chen TY, et al. Among authors: chen hh. Jpn J Clin Oncol. 2003 Jul;33(7):331-5. doi: 10.1093/jjco/hyg064. Jpn J Clin Oncol. 2003. PMID: 12949058

6

Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.

Lee WY, Su WC, Lin PW, Guo HR, Chang TW, Chen HH. Lee WY, et al. Among authors: chen hh. Oncology. 2004;66(6):429-38. doi: 10.1159/000079496. Oncology. 2004. PMID: 15452371

7

Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.

Lee WY, Chen HH, Chow NH, Su WC, Lin PW, Guo HR. Lee WY, et al. Among authors: chen hh. Clin Cancer Res. 2005 Mar 15;11(6):2222-8. doi: 10.1158/1078-0432.CCR-04-1761. Clin Cancer Res. 2005. PMID: 15788670

8

Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.

Chen HH, Su WC, Chou CY, Guo HR, Ho SY, Que J, Lee WY. Chen HH, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1093-100. doi: 10.1016/j.ijrobp.2005.03.062. Epub 2005 Aug 15. Int J Radiat Oncol Biol Phys. 2005. PMID: 16099602

9

Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer.

Chen HH, Su WC, Lin PW, Guo HR, Lee WY. Chen HH, et al. Breast Cancer Res Treat. 2007 Jun;103(2):167-75. doi: 10.1007/s10549-006-9360-3. Epub 2006 Sep 21. Breast Cancer Res Treat. 2007. PMID: 17028975

10

Single cell phospho-specific flow cytometry can detect dynamic changes of phospho-Stat1 level in lung cancer cells.

Lin CC, Huang WL, Su WP, Chen HH, Lai WW, Yan JJ, Su WC. Lin CC, et al. Among authors: chen hh. Cytometry A. 2010 Nov;77(11):1008-19. doi: 10.1002/cyto.a.20965. Cytometry A. 2010. PMID: 20814891 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,001 results

Search Page

Filters